| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |